Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowenstein

Showing results (381-390 of 436) with videos related to

Pageof 44
Sort By:
Cancer Research|August 17, 2005
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma modelSumia Ali, Gwendalyn D King, James F Curtin, et al.
Human Gene Therapy Methods|September 7, 2012
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialA K M Ghulam Muhammad, Weidong Xiong, Mariana Puntel, et al.
Neoplasia (New York, N.Y.)|August 14, 2014
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapyGregory J Baker, Viveka Nand Yadav, Sebastien Motsch, et al.
Journal of Neuro-Oncology|September 18, 2007
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionMarianela Candolfi, James F Curtin, W Stephen Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple MetastasesHania A Al-Hallaq, Steven J Chmura, Joseph K Salama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2005
Regulatable gene expression systems for gene therapy applications: progress and future challengesS Goverdhana, M Puntel, W Xiong, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelYohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathologyDaniel Larocque, Nicholas S R Sanderson, Josée Bergeron, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2007
One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implicationsCarlos Barcia, Maximiliano Jimenez-Dalmaroni, Kurt M Kroeger, et al.
Iscience|August 30, 2020
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet TherapyJantzen Sperry, Michael C Condro, Lea Guo, et al.
Pageof 44

Showing results (381-390 of 436) with videos related to

Sort By:
Pageof 44
Cancer Research|August 17, 2005
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma modelSumia Ali, Gwendalyn D King, James F Curtin, et al.
Human Gene Therapy Methods|September 7, 2012
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialA K M Ghulam Muhammad, Weidong Xiong, Mariana Puntel, et al.
Neoplasia (New York, N.Y.)|August 14, 2014
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapyGregory J Baker, Viveka Nand Yadav, Sebastien Motsch, et al.
Journal of Neuro-Oncology|September 18, 2007
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionMarianela Candolfi, James F Curtin, W Stephen Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple MetastasesHania A Al-Hallaq, Steven J Chmura, Joseph K Salama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2005
Regulatable gene expression systems for gene therapy applications: progress and future challengesS Goverdhana, M Puntel, W Xiong, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelYohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathologyDaniel Larocque, Nicholas S R Sanderson, Josée Bergeron, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2007
One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implicationsCarlos Barcia, Maximiliano Jimenez-Dalmaroni, Kurt M Kroeger, et al.
Iscience|August 30, 2020
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet TherapyJantzen Sperry, Michael C Condro, Lea Guo, et al.
Pageof 44